Derek T Chalmers - Net Worth and Insider Trading
Derek T Chalmers Net Worth
The estimated net worth of Derek T Chalmers is at least $333,509 dollars as of 2024-11-13. Derek T Chalmers is the President & CEO of Cara Therapeutics Inc and owns about 991,405 shares of Cara Therapeutics Inc (CARA) stock worth over $333,509. Details can be seen in Derek T Chalmers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Derek T Chalmers has not made any transactions after 2021-09-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Derek T Chalmers
Derek T Chalmers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Derek T Chalmers owns 2 companies in total, including Cara Therapeutics Inc (CARA) , and Arena Pharmaceuticals Inc (ARNA) .
Click here to see the complete history of Derek T Chalmers’s form 4 insider trades.
Insider Ownership Summary of Derek T Chalmers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2021-09-07 | director & President & CEO |
| ARNA | Arena Pharmaceuticals Inc | 2004-06-11 | other: Former VP & Research and Dir. |
Derek T Chalmers Latest Holdings Summary
Derek T Chalmers currently owns a total of 1 stock. Derek T Chalmers owns 991,405 shares of Cara Therapeutics Inc (CARA) as of September 7, 2021, with a value of $333,509.
Latest Holdings of Derek T Chalmers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2021-09-07 | 991,405 | 0.34 | 333,509 |
Holding Weightings of Derek T Chalmers
Derek T Chalmers Form 4 Trading Tracker
According to the SEC Form 4 filings, Derek T Chalmers has made a total of 18 transactions in Cara Therapeutics Inc (CARA) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Cara Therapeutics Inc is the sale of 20,000 shares on September 7, 2021, which brought Derek T Chalmers around $309,400.
Insider Trading History of Derek T Chalmers
- 1
Derek T Chalmers Trading Performance
Derek T Chalmers Ownership Network
Ownership Network List of Derek T Chalmers
Ownership Network Relation of Derek T Chalmers
Derek T Chalmers Owned Company Details
What does Cara Therapeutics Inc do?
Who are the key executives at Cara Therapeutics Inc?
Derek T Chalmers is the director & President & CEO of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .
Cara Therapeutics Inc (CARA) Insider Trades Summary
Over the past 18 months, Derek T Chalmers made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 60,412 shares made by Christopher Posner , a net sale of 5,476 shares made by Joana Goncalves , and a net sale of 5,236 shares made by Scott Terrillion .
In summary, during the past 3 months, insiders sold 3,668 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 3,668 shares. During the past 18 months, 74,117 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 74,117 shares.
Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cara Therapeutics Inc Insider Transactions
Derek T Chalmers Mailing Address
Above is the net worth, insider trading, and ownership report for Derek T Chalmers. You might contact Derek T Chalmers via mailing address: C/o Cara Therapeutics, Inc., 1 Parrott Drive, Shelton Ct 06484.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
